8QQ:FRA
AbCellera Biologics Inc
€10.50
arrow_downward
-0.76%(-0.080) 1D
Oct 20, 8:47:35 AM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 8QQ...
Open
€10.50
High
€10.50
Low
€10.50
Mkt. cap
3.84B
Avg. vol.
264.00
Volume
0.00
52-wk high
€12.96
52-wk low
€2.49
No. of employees
562
Open
€10.50
High
€10.50
Low
€10.50
Mkt. cap
3.84B
Avg. vol.
264.00
Volume
0.00
52-wk high
€12.96
52-wk low
€2.49
No. of employees
562
News stories
From web sources and news partners
Investor's Business Daily
·
24 minutes ago
Dow Jones Leader Coca-Cola Breaks Out As Stock Market Volatility Ramps Up
ChartMill
·
1 hour ago
Most Active S&P 500 Stocks in Today's Session
FXEmpire
·
1 hour ago
Dow Jones Price Forecast: Bulls Eye 57,000 as October 6 Low Remains Key
Insider Monkey
·
2 hours ago
Ciena (CIEN): Is the AI-Optical Boom Enough to Carry It Into the S&P 500?
Profile
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
About AbCellera Biologics Inc
CEOCarl Hansen
Employees562
Founded2012
HeadquartersVancouver, British Columbia, Canada
SectorHealth care
Websiteabcellera.com